Thyrocare Q1 profit rises 34% YoY to ₹51.3 crore
PharmEasy-owned diagnostics provider Thyrocare reported Q1 FY27 revenue from operations of ₹240 crore, up 24.4% year-on-year, while total expenses rose 19.8% to ₹176.6 crore.
PharmEasy-owned diagnostic services provider Thyrocare reported Q1 FY27 consolidated profit of ₹51.3 crore, up 34% year-on-year, as operating revenue rose 24.4% to ₹240 crore. Expenses increased 19.8% to ₹176.6 crore.
Why this matters
No related recent Thyrocare signals were provided. Q1 FY27 results show profit and revenue growth exceeding the rise in total expenses.
Retail-company signals are accelerating, up 1,046,300% QoQ.
Also reported by
- Inc42 · Buzz — Same time